Eva Ortega (National Node Director)
Nuria Montserrat Pulido (Director of the National Platform for Biobank and Biomodels-ISCIII)
The Kingdom of Spain is represented to the Assembly of Members by the Carlos III Institute of Health (ISCIII), a public research organisation which depends on the Ministry of Science and Innovation and the Ministry of Health.
Spain has also nominated the National Platform for Biobank and Biomodels, ISCIII, as the National Node.
The ISCIII Biobanks and Biomodels Platform is an initiative of the Carlos III Health Institute. This Platform is structured into four scientific-technological HUBS: Biobanks, Organoids, Animal Models and 3D Printing.
The vision of the ISCIII Biobanks and Biomodels Platform is to become a national and international model for companies, clinical institutions, and research and administrative bodies as a common infrastructure that enables researchers to perform – from scientific, technological and regulatory perspectives – a complete preclinical validation ranging from the design to the in vivo validation of the product.
The Biobank Hub of the ISCIII Biobanks and Biomodels Platform contains 34 biobanks located throughout our country and another 15 associated biobanks (currently), forming a completely Spanish biobank ecosystem.
The common goal of both ISCIII and the Biobanks HUB is to make the biological specimens and associated data available for (inter)national biomedical research and to offer researchers multi-centre sample collections. Our aim is to improve the competitiveness of the Spanish biomedical and health research system by providing researchers with centralised access to collections and sample associated data. Our cutting edge services also include advising on issues in the ethical and legal realm.
The Spanish Biobank Hub commitment is not limited to the Spanish biobank community. With many of their experts acting in the BBMRI-ERIC common services area as well as in European working groups, The Spanish Biobank Hub also strongly supports biobank developments in Europe.
Read our press release to learn more here.